Letter

Transparency in NICE

Construction and assumptions of models should be explicit

BMJ 2007; 334 doi: 10.1136/bmj.39185.472743.3A (Published 19 April 2007)
Cite this as: BMJ 2007;334:814.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Tom Fahey, professor of general practice and family medicine
  1. Royal College of Surgeons in Ireland Medical School, Mercers Medical Centre, Dublin 2
  1. tomfahey{at}rcsi.ie

    The National Institute for health and Clinical Excellence (NICE) uses Markov modelling, a form of decision analysis that models the effectiveness and cost effectiveness of drugs or other medical interventions in a cohort of patients over time.1 2 Construction of a Markov model relies on judgments of …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular